[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condbio:solid-neoplasm:g1-s-specific-cyclin-e1":3},{"condition":4,"biomarker":5,"total":6,"trials":7},"Solid Neoplasm","G1\u002FS-Specific Cyclin-E1",9,[8,16,22,29,36,42,48,53,59],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT05687136","Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and Tuvusertib (M1774) for Advanced Solid Tumors",[12],"Phase 1","RECRUITING","2026-08-26T02:17:30.145302Z","2026-07-05T05:32:16.811559Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT04855656","Study of Lunresertib Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid Tumors",[12],"2026-08-26T02:19:19.975067Z","2026-05-05T02:43:28.817590Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":27,"content_modified":28},"NCT02896335","Palbociclib and Pembrolizumab In Central Nervous System Metastases",[26],"Phase 2","2026-08-26T02:18:38.865010Z","2026-07-24T01:27:14.926741Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":34,"content_modified":35},"NCT06726148","Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+\u002FHER2- Breast Cancer and in Patients With Other Advanced Solid Tumors",[33],"Phase 1\u002FPhase 2","2026-08-26T02:18:14.396999Z","2026-07-19T19:36:05.056471Z",{"nct_id":37,"title":38,"phases":39,"status":13,"updated_at":40,"content_modified":41},"NCT07029399","A Study With NKT5097 for Adults With Advanced\u002FMetastatic Solid Tumors",[12],"2026-08-26T02:15:53.461103Z","2026-06-16T05:54:07.931783Z",{"nct_id":43,"title":44,"phases":45,"status":13,"updated_at":46,"content_modified":47},"NCT06997029","A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors",[12],"2026-08-26T02:18:01.700186Z","2026-05-05T02:43:26.752915Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":46,"content_modified":52},"NCT05867251","Study of AVZO-021 in Patients With Advanced Solid Tumors",[33],"2026-05-05T02:43:29.354579Z",{"nct_id":54,"title":55,"phases":56,"status":13,"updated_at":57,"content_modified":58},"NCT05735080","Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer",[33],"2026-08-26T02:18:36.226508Z","2026-05-05T02:43:26.743725Z",{"nct_id":60,"title":61,"phases":62,"status":13,"updated_at":63,"content_modified":64},"NCT06586957","A Study With NKT3964 for Adults With Advanced\u002FMetastatic Solid Tumors",[12],"2026-08-26T02:15:23.202838Z","2026-04-29T02:57:57.069931Z"]